Kathleen Behrens Wilsey is a co-founder of Kew Group, a Cambridge, MA-based firm integrating the use of known cancer biomarkers into the community oncology treatment setting. She is a former partner at Robertson Stephens Investments. She was a general partner for selected venture funds for RS Investments and a director of the Board on Science, Technology and Economic Policy for the National Research Council. She was a director, president, and chairwoman of the National Venture Capital Association.
Residential
Links: kewinc.com
By: Champion3
